House M.D. episode tested as health education tool for rare brain infection
NCT ID NCT07208656
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether watching a single episode of the medical drama House M.D. can boost knowledge about neurocysticercosis, a parasitic brain infection that can cause epilepsy. Sixty young adults aged 18-35 will be randomly assigned to either watch the episode or not, and their knowledge will be measured before and after. The goal is to see if entertainment can effectively educate the public about this neglected disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Medical TV drama episode (House M.D., Season 1, Episode 1)
What this could lead to
If it works, this could show that medical TV dramas are a useful tool for raising awareness about neglected diseases like neurocysticercosis.
What could go wrong
This is a very small, early-stage study (60 people) that only measures short-term knowledge change, not real-world behavior or health outcomes. The effect may be small or not last.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••